Surrozen to Present at The Stifel 2021 Virtual Healthcare Conference

Rhea-AI Summary

Surrozen, a biotechnology company focused on Wnt pathway modulation, announced that CEO Craig Parker will present at the Stifel 2021 Virtual Healthcare Conference on November 16 at 4:40 p.m. ET. Interested individuals can access the live webcast through the Investors section of Surrozen's website, where a replay will also be available. The company is engaged in developing tissue-specific antibodies aimed at enhancing biological repair mechanisms, targeting diseases like inflammatory bowel disease, hepatitis, and certain neurological disorders. For more details, visit surrozen.com.

SOUTH SAN FRANCISCO, Calif., Nov. 05, 2021 (GLOBE NEWSWIRE) -- Surrozen, Inc., (Nasdaq: SRZN), a biotechnology company discovering and developing drug candidates to selectively modulate the Wnt pathway, today announced that Craig Parker, Chief Executive Officer, will present at the Stifel 2021 Virtual Healthcare Conference at 4:40 p.m. ET on Tuesday, November 16. Interested parties may access the live webcast via the Investors section of the Surrozen website at www.surrozen.com. A replay of the webcast will be archived on the website.

About Surrozen

Surrozen is a biotechnology company discovering and developing drug candidates to selectively modulate the Wnt pathway. Surrozen is developing tissue-specific antibodies designed to engage the body’s existing biological repair mechanisms with potential application across multiple disease areas, including inflammatory bowel disease, hepatitis, eye diseases, hearing loss, lung and airway diseases, and certain neurological disorders. For more information, please visit surrozen.com.

Media Contact:
Ian Stone, Managing Director
CanaleComm
Tel.: (619) 518-3518
Email: ian.stone@canalecomm.com

Investor Contact:
Email: Investorinfo@surrozen.com

FAQ

When is Surrozen's presentation at the Stifel 2021 Virtual Healthcare Conference?

Surrozen's presentation will take place on November 16, 2021, at 4:40 p.m. ET.

How can I access the live webcast of Surrozen's conference presentation?

The live webcast can be accessed via the Investors section of Surrozen's website.

What is the focus of Surrozen's drug candidates?

Surrozen focuses on selectively modulating the Wnt pathway to develop drug candidates for various diseases.

What diseases is Surrozen targeting with its therapies?

Surrozen is targeting diseases including inflammatory bowel disease, hepatitis, eye diseases, and neurological disorders.

Where can I find more information about Surrozen?

More information about Surrozen can be found on their website at www.surrozen.com.